You can order this product on prescription after adding it in your basket on checkout .
Revofil Ultra 1x1ml Dermal Filler zoom

Hover

Revofil Ultra zoom

Hover

Revofil Ultra zoom

Hover

Revofil Ultra zoom

Hover

Revofil Ultra zoom

Hover

Revofil Ultra 1x1ml Dermal Filler
Revofil Ultra
Revofil Ultra
Revofil Ultra
Revofil Ultra
Full Screen
Revofil

Revofil Ultra 1x1ml

Out of Stock

Restocking in 48 hours

£35.00( excl. VAT )

Want it delivered by Tomorrow? Order by 3pm
Order within 0h 0m 0s

£35.00( excl. VAT )

Let’s talk on WhatsApp

RevofilĀ® Ultra 1 mL is a cross-linked hyaluronic acid dermal filler formulated for correction of moderate to deep facial wrinkles and structural contour enhancement. As part of the Revofil filler range, it combines volumising HA with peptide components to provide durable lift and smooth tissue integration. Intended exclusively for professional aesthetic use, Revofil Ultra supports defined facial contours while maintaining natural expression.

Description

RevofilĀ® Ultra 1 Ɨ 1 mL Dermal Filler

RevofilĀ® Ultra is an injectable hyaluronic acid (HA) dermal filler developed using a combination of cross-linked hyaluronic acid and biomimetic peptides. As part of the Revofil filler range, this formulation is designed for the correction of moderate to deep facial wrinkles and for structural contour enhancement. The product integrates volumising HA technology with peptide components intended to support dermal matrix stability.

Revofil Ultra is positioned as a higher-density option within the Revofil portfolio, offering increased lifting capacity compared with lighter variants. It is intended for mid- to deep-dermal placement, providing structured volume restoration while maintaining natural facial movement.

What RevofilĀ® Ultra Is Similar To

Revofil Ultra can be regarded alongside other cross-linked hyaluronic acid dermal fillers designed for moderate to deep wrinkle correction and contour enhancement. Compared with standard HA-only fillers, Revofil filler formulations incorporate peptide components as part of their proprietary technology.

Within the Revofil range, Ultra provides greater density and structural support than lighter options intended for fine lines. Treatment selection depends on wrinkle depth, anatomical location, and practitioner assessment. This comparison is provided for clinical orientation only and does not imply interchangeability.

Treatment Areas / Indications

According to manufacturer documentation, Revofil Ultra is indicated for correction of moderate to deep facial wrinkles and restoration of facial volume.

Treatment areas may include:
Nasolabial folds • Marionette lines • Cheeks • Chin • Jawline • Facial contours

→ Revofil Ultra is intended for mid- to deep-dermal applications rather than superficial fine-line treatment.

Usage / Administration (IFU-only)

Injection depth: Mid-dermal to deep dermal layer.
Volume per point / injection site: Not provided by manufacturer.
Needle gauge: Supplied sterile; refer to packaging for specifications.
Frequency / number of sessions: Not provided by manufacturer.
Professional-use disclaimer: Administered only by qualified medical professionals under aseptic conditions.

If any parameter is omitted in the official IFU, it is marked as ā€œnot provided by manufacturer.ā€

Ingredient List

Cross-linked hyaluronic acid (non-animal origin)

Biomimetic peptides (as per manufacturer formulation)

Physiological buffer solution

Other excipients as per IFU; additional trace components not disclosed.

Lidocaine: Verify packaging for specific variant.

Presentation & Longevity

Presentation: 1 Ɨ 1 mL sterile pre-filled syringe
Shelf-life: Not specified in public documentation; refer to packaging for expiry date.
Longevity (treatment duration): Results are typically reported to last approximately 9–12 months, depending on treatment area, injection technique, and individual metabolism.

Safety Notes / Contraindications

Use is contraindicated in patients with known hypersensitivity to hyaluronic acid, peptide components, or any product ingredient.

Avoid use in patients with active infection or inflammation at the injection site.

Do not inject intravascularly.

Appropriate anatomical knowledge and correct injection technique are essential to minimise complications.

Single use only; do not reuse the syringe; ensure packaging is intact and within expiry.

Regulatory Status

CE-marked medical device (where applicable).
UKCA status: verify via IFU or authorised distributor.
Regulatory classification may vary by jurisdiction; verify on the product packaging or manufacturer’s IFU.

FAQ

1. What is Revofil Ultra used for?
Revofil Ultra is used for correction of moderate to deep facial wrinkles and for restoration of facial volume in areas requiring structural support.

2. How is Revofil Ultra different from other Revofil products?
Within the Revofil filler range, Ultra provides higher density and lifting capacity compared with lighter formulations intended for superficial wrinkles.

3. What does ā€œrevofil behandlingā€ mean?
ā€œRevofil behandlingā€ refers to a treatment performed using Revofil dermal filler products by a qualified aesthetic professional.

4. How long do Revofil Ultra results last?
Results are typically reported to last between 9 and 12 months, depending on individual factors and treatment area.

5. Where can professionals purchase Revofil Ultra?
Searches such as ā€œrevofil ultra kaufenā€ generally refer to purchasing through authorised medical distributors. Availability depends on regional regulations.

0/5 (0 Reviews)

FAQs

No Faq found.

Shop By Brand

We stock, the industries favourite brands for all aesthetic practices. Explore what these top brands have to offer.